Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Indoco Remedies Ltd. Board/Management Information 2021

Jun 11, 2021

62453_rns_2021-06-11_c4bf43e9-e6b1-4e00-b299-a876822da97c.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

==> picture [199 x 70] intentionally omitted <==

June 11, 2021

ToThe ManagerListing DepartmentNational Stock Exchange of India Limited‘Exchange Plaza’, C - 1, Block G,Bandra-Kurla Complex,Bandra (E), Mumbai 400051.ScripCode: INDOCO ToBSE LimitedCorporate Relationship Department1stFloor, New Trading Ring,Phiroze Jeejeebhoy TowersDalal StreetMumbai 400001ScripCode : 532612

Dear Sirs,

Sub.: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015

Resignation of Chief Financial Officer

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) regulation, 2015, this is to inform you that Mr. Mandar Borkar, Chief Financial Officer and Key Managerial Personnel at Indoco Remedies Limited has tendered his resignation to explore new opportunities outside the Company and will be relieved from his duties with effect from June 18, 2021.

The Company is in the process of appointing a new Chief Financial Officer and the same will be communicated to the Stock Exchange in due course.

Kindly take the above information on your records.

Yours faithfully,

for Indoco Remedies Limited

Jayshankar Menon Company Secretary Membership No: A 11067

==> picture [49 x 47] intentionally omitted <==

==> picture [593 x 142] intentionally omitted <==